NatWest Group Receives Analyst Upgrade from BNP Paribas Signals Growing Confidence Beyond Oil and Iran Consumer Prices Reaccelerate Across Multiple Sectors Market Pricing Signals No Fed Rate Cut Before 2027 After Hot Inflation Data Lowes Companies LOW Faces Price Target Reduction Amidst Market Adjustments Alain Prost Injured in Home Raid Safety Concerns for HighProfile Figures Morrisons Plans to Shut Around 100 Stores Amid Rising Cost Pressures TEAM Q1 2026 Earnings Strong EPS Beat Drives Stock Rally OPCH Q1 2026 Earnings EPS Beats Estimates Stock Declines Despite Beat WM Q1 2026 Earnings Slight EPS Beat Amid Steady Operations Stock Edges Higher FLR Q1 2026 Earnings EPS Misses Estimates by Wide Margin Stock Edges Higher Celanese Corporation Q1 2026 Earnings EPS Miss Amid Cost Headwinds Stock Edges Lower APYX Q1 2026 Earnings Strong EPS Beat Highlights Cost Discipline Amid Revenue Uncertainty 4D Molecular Therapeutics FDMT Gains 16 as Stock Holds Above Support WaterBridge Infrastructure WBI Faces Pressure Price Drops Nearly 5 ONEOK Inc OKE Retreats 15 as Resistance Holds Near 9353 Eaton Vance Municipal Income Trust EOT Edges Higher Support and Resistance Levels in Focus Hercules Capital 625 Notes Due 2033 HCXY Holds Steady Near Support as FixedIncome Market Watches Rate Signals Consumer Sentiment Plunges to Record Low in May Amid Iran Conflict and Oil Price Surge ThredUp TDUP Q1 2026 Earnings Narrow Loss Beats Estimates but Stock Slips on Revenue Concerns Lucas GC Limited LGCL Edges Higher Testing Key Resistance Levels Vera Bradley VRA Q1 2026 Earnings Strong EPS Beat Amidst Uncertain Revenue Picture WALD Q4 2024 Earnings EPS Misses Estimates Significantly as Stock Rises Brighthouse Financial BHFAM Q1 2026 Earnings EPS Misses Estimates Amid Challenging Environment Shares Edge Higher CLDX Q1 2026 Earnings Celldex Reports EPS Miss Amid EarlyStage Pipeline Progress RPAY Q1 2026 Earnings EPS Beat Drives 418 Stock Rally Despite Missing Revenue Details NovaBridge Biosciences NBP Q4 2025 Earnings Staggering EPS Miss as PreRevenue Biotech Faces Development Headwinds ENIC Q4 2025 Earnings EPS Beat Surprises Market Despite Stock Decline